This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tibotec Pharmaceuticals Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovator Dirk Edward Désiré Jochmans: A Pioneer in Anti-Infective Compounds
Introduction
Dirk Edward Désiré Jochmans is an accomplished inventor based in Herent, Belgium. His innovative contributions to the field of medicine have led to the development of anti-infective compounds, demonstrating his commitment to advancing healthcare.
Latest Patents
Jochmans holds a patent for "Substituted indolepyridinium as anti-infective compounds." This groundbreaking invention pertains to compounds of a specific formula, including their N-oxides, salts, and various stereoisomeric forms. These compounds, characterized by diverse substituents, are designed for use as medicinal agents, showcasing Jochmans's significant impact on pharmaceutical research.
Career Highlights
His professional journey includes a key role at Tibotec Pharmaceuticals Ltd., where he has been instrumental in the research and development of novel anti-infective therapies. His work has not only enhanced the company's portfolio but has also contributed to the broader scientific community's understanding of effective medicinal compounds.
Collaborations
Jochmans has collaborated with notable coworkers Bart Rudolf Romanie Kesteleyn and Wim Van De Vreken. Their joint efforts enrich the research environment at Tibotec Pharmaceuticals Ltd., fostering innovation and the pursuit of new treatments for infectious diseases.
Conclusion
In conclusion, Dirk Edward Désiré Jochmans stands out as a dedicated inventor whose work in anti-infective compounds is paving the way for advancements in medicine. His patent reflects a significant achievement in the fight against infections, and his collaborative spirit continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
